DiviDrip · AQST

AQST — Aquestive Therapeutics, Inc. Common Stock

AQST is Aquestive Therapeutics, Inc. Common Stock (Healthcare) — a non-dividend-paying stock. Trading at $5.34. Market cap: $670M. Capital Quality Rank: 5/100 — Systemic risk.

Stock snapshot

Price$5.34
Market cap$670M
SectorHealthcare
ExchangeXNAS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)5 / 100 · Systemic risk
Revenue CAGR (3y)-2.2%
Shareholder buyback yield-18.89%
Altman Z-score zoneDistress

About AQST

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Listed2018Employees147HQWarren, NJSectorHealthcareWebsiteaquestive.com

Related non-dividend companies

Other non-dividend stocks investors research alongside AQST. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is AQST's current stock price?

AQST (Aquestive Therapeutics, Inc. Common Stock) is currently trading at $5.34.

Does AQST pay a dividend?

AQST (Aquestive Therapeutics, Inc. Common Stock) does not currently pay a regular dividend.

What is AQST's Capital Quality Rank?

AQST has a Capital Quality Rank of 5/100 — Systemic risk. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track AQST in DiviDrip

Add AQST to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow